Immunostaining with the anti‐Epfn antibody revealed that more than half of the chief cells in the PTgs were positive (Fig. 6A, Epfn), whereas the parathyroid adenoma specimens in all cases had much lower immunoreactivity against Epfn (Fig. 6A–C). This evidence concerns the gene SP6 and parathyroid gland adenoma.